We conducted this study to summarize the results of studies reporting the role of NLR (neutrophil to lymphocyte ratio) in PSCC (penile squamous cell carcinoma).
This meta-analysis was conducted using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria. A systematic search was conducted on PubMed, Scopus, and web of science up to March 10, 2023. Fourteen studies were included in the review. The NOS (Newcastle-Ottawa Scale) was used to determine the quality of the included studies. This meta-analysis was conducted on the studies reporting the relationship between NLR and survival using HR (hazard ratio) and 95% CI (confidence interval).
There was a significant association between NLR levels and the prognosis, nodal stage, and anatomical tumor stage of PSCC patients. In the meta-analysis of the association of NLR with survival, NLR level was significantly associated with lower cancer-specific survival (HR = 3.51, 95% CI = 2.07-5.98, p < 0.001) and lower disease-free survival (HR = 2.88, 95% CI = 1.60-5.20, p < 0.001). However, NLR was found to have no association with the stage, grade, location, and size of the tumor.
NLR has a significant diagnostic and prognostic value in PSCC.
BMC urology. 2024 Sep 06*** epublish ***
Saghar Babadi, Matin Moallem Shahri, Sima Foroughi Nematollahi, Arnav Barpujari, Alec Clark, Brandon Lucke-Wold, Shirin Sarejloo, Arshin Ghaedi, Aida Bazrgar, Shokoufeh Khanzadeh
Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran., Division of Transplant Services, Department of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA., Kerman University of Medical Sciences, Kerman, Iran., Department of Neurosurgery, University of Florida, Gainesville, USA., College of Medicine, University of Central Florida, Orlando, USA., Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Tabriz University of Medical Sciences, Tabriz, Iran. .